nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—SLC6A4—conduct disorder	0.467	0.566	CbGaD
Mianserin—HTR2A—conduct disorder	0.359	0.435	CbGaD
Mianserin—SLC6A2—autonomic nervous system—conduct disorder	0.00558	0.2	CbGeAlD
Mianserin—HTR7—autonomic nervous system—conduct disorder	0.00538	0.193	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—conduct disorder	0.00335	0.12	CbGeAlD
Mianserin—HTR1F—brain—conduct disorder	0.00165	0.0591	CbGeAlD
Mianserin—DRD3—brain—conduct disorder	0.00116	0.0417	CbGeAlD
Mianserin—HTR6—brain—conduct disorder	0.00112	0.0402	CbGeAlD
Mianserin—Mirtazapine—DRD4—conduct disorder	0.0011	0.167	CrCbGaD
Mianserin—OPRK1—brain—conduct disorder	0.00104	0.0372	CbGeAlD
Mianserin—HRH2—brain—conduct disorder	0.00102	0.0367	CbGeAlD
Mianserin—SLC6A3—brain—conduct disorder	0.000669	0.024	CbGeAlD
Mianserin—Mirtazapine—SLC6A4—conduct disorder	0.00066	0.1	CrCbGaD
Mianserin—HTR1D—brain—conduct disorder	0.000653	0.0234	CbGeAlD
Mianserin—HTR2C—brain—conduct disorder	0.000647	0.0232	CbGeAlD
Mianserin—Epinastine—HTR2A—conduct disorder	0.000644	0.0977	CrCbGaD
Mianserin—SLC6A4—brain—conduct disorder	0.000613	0.022	CbGeAlD
Mianserin—HTR2B—brain—conduct disorder	0.000607	0.0218	CbGeAlD
Mianserin—HTR1A—brain—conduct disorder	0.000544	0.0195	CbGeAlD
Mianserin—SLC6A2—brain—conduct disorder	0.00054	0.0194	CbGeAlD
Mianserin—HTR7—brain—conduct disorder	0.00052	0.0187	CbGeAlD
Mianserin—Mirtazapine—HTR2A—conduct disorder	0.000507	0.0769	CrCbGaD
Mianserin—DRD2—brain—conduct disorder	0.000492	0.0177	CbGeAlD
Mianserin—Cyproheptadine—HTR2A—conduct disorder	0.000492	0.0746	CrCbGaD
Mianserin—ADRA2C—brain—conduct disorder	0.000478	0.0172	CbGeAlD
Mianserin—Nortriptyline—SLC6A4—conduct disorder	0.000433	0.0658	CrCbGaD
Mianserin—Trimipramine—SLC6A4—conduct disorder	0.000408	0.0619	CrCbGaD
Mianserin—CYP2B6—brain—conduct disorder	0.000398	0.0143	CbGeAlD
Mianserin—HRH1—brain—conduct disorder	0.000388	0.0139	CbGeAlD
Mianserin—ADRA2A—brain—conduct disorder	0.000381	0.0137	CbGeAlD
Mianserin—Desipramine—SLC6A4—conduct disorder	0.000357	0.0541	CrCbGaD
Mianserin—Nortriptyline—HTR2A—conduct disorder	0.000333	0.0505	CrCbGaD
Mianserin—HTR2A—brain—conduct disorder	0.000324	0.0116	CbGeAlD
Mianserin—Trimipramine—HTR2A—conduct disorder	0.000314	0.0476	CrCbGaD
Mianserin—Imipramine—SLC6A4—conduct disorder	0.000303	0.0459	CrCbGaD
Mianserin—Amitriptyline—SLC6A4—conduct disorder	0.000301	0.0456	CrCbGaD
Mianserin—CYP2D6—brain—conduct disorder	0.000295	0.0106	CbGeAlD
Mianserin—Desipramine—HTR2A—conduct disorder	0.000274	0.0416	CrCbGaD
Mianserin—Imipramine—HTR2A—conduct disorder	0.000233	0.0353	CrCbGaD
Mianserin—Amitriptyline—HTR2A—conduct disorder	0.000231	0.0351	CrCbGaD
Mianserin—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.000114	0.000818	CbGpPWpGaD
Mianserin—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000113	0.000808	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—DRD4—conduct disorder	0.000109	0.000779	CbGpPWpGaD
Mianserin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000108	0.000774	CbGpPWpGaD
Mianserin—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000107	0.000765	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—CGA—conduct disorder	0.000107	0.000761	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.000106	0.000757	CbGpPWpGaD
Mianserin—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000105	0.00075	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.000105	0.00075	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000105	0.000747	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000102	0.000731	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000102	0.000727	CbGpPWpGaD
Mianserin—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000101	0.000724	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000101	0.000724	CbGpPWpGaD
Mianserin—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000101	0.000722	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—DRD4—conduct disorder	0.000101	0.000721	CbGpPWpGaD
Mianserin—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000101	0.00072	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.000101	0.00072	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—WASF1—conduct disorder	9.98e-05	0.000714	CbGpPWpGaD
Mianserin—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.96e-05	0.000712	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	9.89e-05	0.000707	CbGpPWpGaD
Mianserin—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.8e-05	0.000701	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	9.8e-05	0.000701	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—CGA—conduct disorder	9.66e-05	0.00069	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—CGA—conduct disorder	9.62e-05	0.000687	CbGpPWpGaD
Mianserin—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	9.41e-05	0.000672	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—CGA—conduct disorder	9.28e-05	0.000664	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	9.25e-05	0.000661	CbGpPWpGaD
Mianserin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	9.25e-05	0.000661	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—CGA—conduct disorder	9.24e-05	0.00066	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—WASF1—conduct disorder	9.21e-05	0.000659	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—DRD4—conduct disorder	9.16e-05	0.000655	CbGpPWpGaD
Mianserin—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	9.06e-05	0.000648	CbGpPWpGaD
Mianserin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.99e-05	0.000643	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—CGA—conduct disorder	8.98e-05	0.000642	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—CGA—conduct disorder	8.98e-05	0.000642	CbGpPWpGaD
Mianserin—HTR6—GPCR ligand binding—HTR2A—conduct disorder	8.93e-05	0.000638	CbGpPWpGaD
Mianserin—HTR7—GPCR ligand binding—HTR2A—conduct disorder	8.92e-05	0.000638	CbGpPWpGaD
Mianserin—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.89e-05	0.000636	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—DRD4—conduct disorder	8.89e-05	0.000636	CbGpPWpGaD
Mianserin—CYP2D6—Biological oxidations—COMT—conduct disorder	8.87e-05	0.000634	CbGpPWpGaD
Mianserin—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	8.86e-05	0.000633	CbGpPWpGaD
Mianserin—HTR7—Circadian rythm related genes—EP300—conduct disorder	8.84e-05	0.000632	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.83e-05	0.000631	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—CGA—conduct disorder	8.81e-05	0.00063	CbGpPWpGaD
Mianserin—CYP2D6—Biological oxidations—MAOA—conduct disorder	8.8e-05	0.000629	CbGpPWpGaD
Mianserin—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.75e-05	0.000626	CbGpPWpGaD
Mianserin—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	8.74e-05	0.000625	CbGpPWpGaD
Mianserin—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.73e-05	0.000624	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—DRD4—conduct disorder	8.73e-05	0.000624	CbGpPWpGaD
Mianserin—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.68e-05	0.00062	CbGpPWpGaD
Mianserin—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.63e-05	0.000617	CbGpPWpGaD
Mianserin—HRH4—GPCR downstream signaling—HTR2A—conduct disorder	8.48e-05	0.000606	CbGpPWpGaD
Mianserin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.4e-05	0.0006	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—CGA—conduct disorder	8.15e-05	0.000583	CbGpPWpGaD
Mianserin—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	8.15e-05	0.000583	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	8.03e-05	0.000574	CbGpPWpGaD
Mianserin—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	8.03e-05	0.000574	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—CGA—conduct disorder	8.02e-05	0.000573	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—CGA—conduct disorder	8e-05	0.000572	CbGpPWpGaD
Mianserin—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.96e-05	0.000569	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.96e-05	0.000569	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	7.85e-05	0.000561	CbGpPWpGaD
Mianserin—HTR1F—GPCR downstream signaling—HTR2A—conduct disorder	7.83e-05	0.00056	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—WASF1—conduct disorder	7.74e-05	0.000553	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—DRD4—conduct disorder	7.73e-05	0.000553	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—DRD4—conduct disorder	7.73e-05	0.000552	CbGpPWpGaD
Mianserin—HRH4—Signaling by GPCR—HTR2A—conduct disorder	7.71e-05	0.000551	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.67e-05	0.000549	CbGpPWpGaD
Mianserin—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.62e-05	0.000545	CbGpPWpGaD
Mianserin—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.58e-05	0.000542	CbGpPWpGaD
Mianserin—DRD3—Circadian rythm related genes—EP300—conduct disorder	7.52e-05	0.000537	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CGA—conduct disorder	7.52e-05	0.000537	CbGpPWpGaD
Mianserin—CYP1A2—Biological oxidations—COMT—conduct disorder	7.51e-05	0.000537	CbGpPWpGaD
Mianserin—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.48e-05	0.000535	CbGpPWpGaD
Mianserin—CYP1A2—Biological oxidations—MAOA—conduct disorder	7.46e-05	0.000533	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CGA—conduct disorder	7.41e-05	0.00053	CbGpPWpGaD
Mianserin—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	7.41e-05	0.000529	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CGA—conduct disorder	7.4e-05	0.000529	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CGA—conduct disorder	7.35e-05	0.000525	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CGA—conduct disorder	7.3e-05	0.000522	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—DRD4—conduct disorder	7.13e-05	0.000509	CbGpPWpGaD
Mianserin—HTR1F—Signaling by GPCR—HTR2A—conduct disorder	7.11e-05	0.000508	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	7.06e-05	0.000505	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—DRD4—conduct disorder	7.02e-05	0.000502	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—DRD4—conduct disorder	7.02e-05	0.000501	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—DRD4—conduct disorder	6.98e-05	0.000499	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—DRD4—conduct disorder	6.97e-05	0.000498	CbGpPWpGaD
Mianserin—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.93e-05	0.000496	CbGpPWpGaD
Mianserin—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	6.85e-05	0.000489	CbGpPWpGaD
Mianserin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.82e-05	0.000488	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CGA—conduct disorder	6.76e-05	0.000483	CbGpPWpGaD
Mianserin—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.61e-05	0.000472	CbGpPWpGaD
Mianserin—HRH2—GPCR downstream signaling—HTR2A—conduct disorder	6.58e-05	0.00047	CbGpPWpGaD
Mianserin—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.58e-05	0.00047	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.57e-05	0.00047	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—DRD4—conduct disorder	6.44e-05	0.00046	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—DRD4—conduct disorder	6.41e-05	0.000458	CbGpPWpGaD
Mianserin—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	6.4e-05	0.000457	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	6.39e-05	0.000457	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—CGA—conduct disorder	6.35e-05	0.000454	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CGA—conduct disorder	6.29e-05	0.00045	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—WASF1—conduct disorder	6.02e-05	0.000431	CbGpPWpGaD
Mianserin—HRH2—Signaling by GPCR—HTR2A—conduct disorder	5.97e-05	0.000427	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.96e-05	0.000426	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—WASF1—conduct disorder	5.94e-05	0.000424	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—WASF1—conduct disorder	5.93e-05	0.000424	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	5.93e-05	0.000424	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.89e-05	0.000421	CbGpPWpGaD
Mianserin—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.8e-05	0.000415	CbGpPWpGaD
Mianserin—CYP3A4—Biological oxidations—COMT—conduct disorder	5.8e-05	0.000414	CbGpPWpGaD
Mianserin—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.76e-05	0.000411	CbGpPWpGaD
Mianserin—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.75e-05	0.000411	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.72e-05	0.000409	CbGpPWpGaD
Mianserin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.72e-05	0.000409	CbGpPWpGaD
Mianserin—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.7e-05	0.000407	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.7e-05	0.000407	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CGA—conduct disorder	5.68e-05	0.000406	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	5.54e-05	0.000396	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CGA—conduct disorder	5.48e-05	0.000392	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CGA—conduct disorder	5.46e-05	0.00039	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—WASF1—conduct disorder	5.42e-05	0.000387	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—DRD4—conduct disorder	5.41e-05	0.000387	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	5.39e-05	0.000385	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CGA—conduct disorder	5.31e-05	0.000379	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—DRD4—conduct disorder	5.2e-05	0.000372	CbGpPWpGaD
Mianserin—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	5.19e-05	0.000371	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—DRD4—conduct disorder	5.17e-05	0.00037	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—CGA—conduct disorder	5.15e-05	0.000368	CbGpPWpGaD
Mianserin—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	5.12e-05	0.000366	CbGpPWpGaD
Mianserin—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	5.05e-05	0.000361	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—WASF1—conduct disorder	5.04e-05	0.00036	CbGpPWpGaD
Mianserin—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	5.04e-05	0.00036	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	5.03e-05	0.00036	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—DRD4—conduct disorder	5.03e-05	0.000359	CbGpPWpGaD
Mianserin—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	5.01e-05	0.000358	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.95e-05	0.000354	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.93e-05	0.000353	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—CGA—conduct disorder	4.83e-05	0.000345	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CGA—conduct disorder	4.81e-05	0.000344	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CGA—conduct disorder	4.74e-05	0.000339	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CGA—conduct disorder	4.73e-05	0.000338	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	4.65e-05	0.000332	CbGpPWpGaD
Mianserin—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	4.61e-05	0.000329	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.58e-05	0.000328	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—HTR2A—conduct disorder	4.58e-05	0.000327	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.56e-05	0.000326	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—WASF1—conduct disorder	4.55e-05	0.000325	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—HTR2A—conduct disorder	4.55e-05	0.000325	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.55e-05	0.000325	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.5e-05	0.000322	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.49e-05	0.000321	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.48e-05	0.00032	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.39e-05	0.000314	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.37e-05	0.000313	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.31e-05	0.000308	CbGpPWpGaD
Mianserin—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	4.29e-05	0.000306	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—WASF1—conduct disorder	4.25e-05	0.000304	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—DRD4—conduct disorder	4.21e-05	0.000301	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—HTR2A—conduct disorder	4.2e-05	0.0003	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	4.18e-05	0.000299	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—DRD4—conduct disorder	4.15e-05	0.000297	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—DRD4—conduct disorder	4.14e-05	0.000296	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—DRD4—conduct disorder	4.12e-05	0.000294	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	4.09e-05	0.000292	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.89e-05	0.000278	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	3.87e-05	0.000277	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—WASF1—conduct disorder	3.86e-05	0.000276	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.8e-05	0.000271	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—WASF1—conduct disorder	3.79e-05	0.000271	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—DRD4—conduct disorder	3.79e-05	0.000271	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.74e-05	0.000267	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.72e-05	0.000266	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	3.61e-05	0.000258	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—HTR2A—conduct disorder	3.53e-05	0.000252	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—DRD4—conduct disorder	3.52e-05	0.000252	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	3.51e-05	0.000251	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.45e-05	0.000247	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.39e-05	0.000242	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.37e-05	0.000241	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CGA—conduct disorder	3.36e-05	0.00024	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	3.28e-05	0.000235	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.28e-05	0.000234	CbGpPWpGaD
Mianserin—ADRA2B—Hemostasis—EP300—conduct disorder	3.24e-05	0.000232	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3.22e-05	0.00023	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—DRD4—conduct disorder	3.18e-05	0.000227	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—DRD4—conduct disorder	3.07e-05	0.00022	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—DRD4—conduct disorder	3.06e-05	0.000218	CbGpPWpGaD
Mianserin—ADRA2C—Hemostasis—EP300—conduct disorder	3.03e-05	0.000217	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.98e-05	0.000213	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—DRD4—conduct disorder	2.97e-05	0.000212	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.94e-05	0.00021	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.92e-05	0.000209	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—COMT—conduct disorder	2.86e-05	0.000205	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CGA—conduct disorder	2.85e-05	0.000203	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—MAOA—conduct disorder	2.84e-05	0.000203	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—HTR2A—conduct disorder	2.75e-05	0.000196	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.71e-05	0.000193	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—HTR2A—conduct disorder	2.7e-05	0.000193	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—DRD4—conduct disorder	2.7e-05	0.000193	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.69e-05	0.000192	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.67e-05	0.000191	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.65e-05	0.00019	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—DRD4—conduct disorder	2.65e-05	0.000189	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—HTR2A—conduct disorder	2.47e-05	0.000177	CbGpPWpGaD
Mianserin—ADRA2A—Hemostasis—EP300—conduct disorder	2.46e-05	0.000176	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.41e-05	0.000173	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—EP300—conduct disorder	2.41e-05	0.000172	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—COMT—conduct disorder	2.33e-05	0.000166	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—MAOA—conduct disorder	2.31e-05	0.000165	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.3e-05	0.000164	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—EP300—conduct disorder	2.23e-05	0.000159	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CGA—conduct disorder	2.2e-05	0.000157	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—COMT—conduct disorder	2.18e-05	0.000156	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—MAOA—conduct disorder	2.17e-05	0.000155	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	2.08e-05	0.000148	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—HTR2A—conduct disorder	2e-05	0.000143	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.99e-05	0.000142	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	1.94e-05	0.000139	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—EP300—conduct disorder	1.87e-05	0.000134	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.76e-05	0.000126	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.73e-05	0.000123	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.57e-05	0.000113	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—COMT—conduct disorder	1.52e-05	0.000108	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MAOA—conduct disorder	1.51e-05	0.000108	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EP300—conduct disorder	1.46e-05	0.000104	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EP300—conduct disorder	1.43e-05	0.000103	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EP300—conduct disorder	1.43e-05	0.000102	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EP300—conduct disorder	1.42e-05	0.000102	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EP300—conduct disorder	1.31e-05	9.36e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—COMT—conduct disorder	1.28e-05	9.18e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MAOA—conduct disorder	1.28e-05	9.12e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.24e-05	8.84e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—EP300—conduct disorder	1.23e-05	8.78e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EP300—conduct disorder	1.22e-05	8.71e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EP300—conduct disorder	1.1e-05	7.86e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EP300—conduct disorder	1.06e-05	7.59e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EP300—conduct disorder	1.06e-05	7.55e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EP300—conduct disorder	1.03e-05	7.34e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—EP300—conduct disorder	9.98e-06	7.13e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—conduct disorder	9.91e-06	7.09e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MAOA—conduct disorder	9.84e-06	7.04e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—EP300—conduct disorder	9.35e-06	6.69e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EP300—conduct disorder	9.32e-06	6.66e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EP300—conduct disorder	9.17e-06	6.56e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EP300—conduct disorder	9.15e-06	6.54e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EP300—conduct disorder	8.34e-06	5.96e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—EP300—conduct disorder	6.5e-06	4.65e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—EP300—conduct disorder	5.51e-06	3.94e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—EP300—conduct disorder	4.25e-06	3.04e-05	CbGpPWpGaD
